Winter 2004: Calypso Medical: GPS for the Body Calypso Medical Technologies, an innovative medical device company, was founded in 1999 to develop novel cancer treatment technologies. Since then, Calypso Medical has been quietly honing their tumor locator technology to create a tool to locate and track tumors “GPS for the Body”.
Spring 2004: RiverVest Invests in Conforma’s New Pathway to Fighting Cancer RiverVest invested $2 million in a $30 million C round for Conforma Therapeutics, a San Diego biotechnology company. RiverVest was one of five new investors in the round led by S.R. One Limited, joining Lilly BioVentures, Novo A/S and RBC Capital Partners, as well […]
Fall 2003: RiverVest Invests in Velocimed, LLC In June, RiverVest Venture Partners participated in a Series C financing round of Velocimed, LLC, investing $3 million. Velocimed is a Minnesota-based developer, manufacturer and marketer of medical devices, whose products will be used in a broad range of interventional cardiology and neurology applications.
Spring 2003: Kereos Appoints Al Beardsley, Ph.D., CEO Robert A. (Al) Beardsley, Ph.D. was appointed president and chief executive officer (CEO) of Kereos and named to its board of directors in January 2003. Kereos and named to its board of directors in January 2003. Kereos is a St. Louis biotechnology company developing targeted therapeutics and molecular […]